welcome to oneEDSvoice- a positively charged Ehlers Danlos Syndrome community.
- join today!
Clinical Autonomic Disorders: A Training Protocol
purpose: Background: – The autonomic nervous system helps control things that happen automatically in the body, like blood pressure, heart rate, and digestion. When it doesn t work properly, it s called dysautonomia. Researchers want to learn more about dysautonomias and train doctors to learn how to better diagnose them. Objectives: To allow people with autonomic disorders to be evaluated. To help fellows in the NIH Autonomic...
sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
location: United States
Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan
purpose: Sudoscan™ (Impeto Medical, Paris France) uses electrochemical skin conductance as a novel noninvasive method to detect sudomotor dysfunction. Several small studies have recently shown that Sudoscan use in the assessment of small fiber polyneuropathy (in diabetes mellitus) can be performed non-invasively, quickly and effectively. The investigators aim to study the use of Sudoscan in rare disease condition associated with small fiber polyneuropat...
sponsor: Massachusetts General Hospital
location: United States
Origins and Impact of EDS in Connective Tissues and Skin
purpose: Ehlers-Danlos Syndrome (EDS) is an inherited disease of collagen, found in connective tissues, such as skin. EDS patients suffer from joint and skin problems (skin hyperextensibility, joint hypermobility) along with a large range of other disorders, including, delayed wound healing with atrophic scarring, easy bruising, tissue fragility, gastrointestinal and gum problems. There are many different types of EDS, with different mechanisms of action,...
sponsor: University College London
location: United Kingdom
Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)
purpose: This study aims to verify the hypothesis that patients with Vascular Ehlers Danlos syndrome (vEDS) should benefit of the blockade of angiotensin (Ang) II noxious effects on their vasculature affected by a defect in type III collagen in addition to the effects celiprolol. This randomized, double blind, placebo controlled trial compares the administration of the Ang II type I receptor blocker (ARB) — irbesartan— to placebo over a 2-year period...
sponsor: Assistance Publique - Hôpitaux de Paris